Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
CTMedic's Profile
Displaying 701-750 of 1653 result(s).
CYDY CytoDyn Inc
12/28/2020 8:01:00 PM
nbmbr1, I believe DSMB is the curre
CYDY CytoDyn Inc
12/28/2020 7:27:02 PM
nbmbr1: DSMB works for Cytodyn. The (2)
CYDY CytoDyn Inc
12/28/2020 6:50:13 PM
Trial isn’t over for 15 days. Enr
CYDY CytoDyn Inc
12/26/2020 4:42:27 PM
Sean, I hope he has his own money o (8)
CYDY CytoDyn Inc
12/26/2020 1:11:51 AM
Shelly, The hard thing for me is to (1)
CYDY CytoDyn Inc
12/25/2020 5:55:15 PM
Ohm20, Merry Christmas and thanks a (2)
CYDY CytoDyn Inc
12/25/2020 4:33:17 PM
Jlang, Maybe the shorts will call i (2)
CYDY CytoDyn Inc
12/25/2020 1:48:50 PM
Carsmax, An absolute world of suffe (1)
CYDY CytoDyn Inc
12/25/2020 12:59:41 PM
Carsmax, ALzheimer’s disease tria
CYDY CytoDyn Inc
12/25/2020 9:04:46 AM
Hoops, Each of the hundreds of thou (21)
CYDY CytoDyn Inc
12/25/2020 6:43:36 AM
Mom, Dad! St. Nader brought gifts t (6)
CYDY CytoDyn Inc
12/24/2020 4:48:17 PM
MidnightJester, Welcome. You are in (3)
CYDY CytoDyn Inc
12/24/2020 1:29:23 PM
Evil Rabbit, Long haulers posted so (3)
CYDY CytoDyn Inc
12/23/2020 8:43:06 PM
Craig, Looked like quite a bit of F (3)
CYDY CytoDyn Inc
12/23/2020 8:20:30 PM
Craigakess, You are correct. Market
CYDY CytoDyn Inc
12/23/2020 11:53:09 AM
Oncoimmune's CD24Fc, as best I am a (5)
CYDY CytoDyn Inc
12/22/2020 8:03:40 PM
Shelly, I could not agree more. Eye (6)
CYDY CytoDyn Inc
12/22/2020 6:59:54 PM
Good news. BioNTech Confident COVID (2)
CYDY CytoDyn Inc
12/22/2020 6:55:39 PM
Another therapeutic approach down t (2)
CYDY CytoDyn Inc
12/22/2020 6:47:03 PM
Jmcll, That is correct. Here is the (1)
CYDY CytoDyn Inc
12/22/2020 9:33:55 AM
Holy cow! 47 cents and a million sh (2)
CYDY CytoDyn Inc
12/22/2020 8:48:24 AM
Lionel, 42 days analysis was added,
CYDY CytoDyn Inc
12/21/2020 8:25:56 PM
Chazzle, Thanks, I am definitely in (3)
CYDY CytoDyn Inc
12/21/2020 6:54:11 PM
Leronlimab treats the immune dysreg (6)
CYDY CytoDyn Inc
12/21/2020 2:44:06 PM
Shelly, WSJ article on leronlimab l (3)
CYDY CytoDyn Inc
12/21/2020 10:53:34 AM
Jlang, I hope your are wrong, but t (4)
CYDY CytoDyn Inc
12/21/2020 9:01:41 AM
Please stop with vaccine conspiraci (2)
CYDY CytoDyn Inc
12/20/2020 6:25:20 AM
CDiddy, I would add that it takes s (7)
CYDY CytoDyn Inc
12/18/2020 9:10:38 PM
Seeking37, Please do your own due d (7)
CYDY CytoDyn Inc
12/18/2020 8:34:24 PM
RTB's analysis is substantially mor (2)
CYDY CytoDyn Inc
12/18/2020 8:18:18 PM
Seeking37, This filing will be imma (6)
CYDY CytoDyn Inc
12/18/2020 8:08:57 PM
Moderna's vaccine given EUA. https: (2)
CYDY CytoDyn Inc
12/18/2020 3:40:46 PM
The trial design is aggressive, but (4)
CYDY CytoDyn Inc
12/18/2020 12:46:06 AM
JLang, I had the same concern with (1)
CYDY CytoDyn Inc
12/17/2020 10:28:06 PM
I expect more movement into Cytodyn (6)
CYDY CytoDyn Inc
12/17/2020 3:04:01 PM
CDIddy, The bigger question for me (7)
CYDY CytoDyn Inc
12/17/2020 9:48:50 AM
Ohm, Thanks as always. The ability
CYDY CytoDyn Inc
12/17/2020 9:09:59 AM
Ohm, Do you believe that Dr Patters
CYDY CytoDyn Inc
12/16/2020 3:07:31 PM
nbmr1, I chose my words poorly. I a (2)
CYDY CytoDyn Inc
12/16/2020 2:41:10 PM
The rational will see that the numb (3)
CYDY CytoDyn Inc
12/15/2020 4:21:19 PM
I skipped over it as well. I don't (2)
CYDY CytoDyn Inc
12/15/2020 4:11:47 PM
And what precedes the body of annou (13)
CYDY CytoDyn Inc
12/15/2020 12:03:52 PM
I can't believe that has lasted ove (2)
CYDY CytoDyn Inc
12/13/2020 5:57:01 PM
Link on Cytodyn website describing (3)
CYDY CytoDyn Inc
12/13/2020 10:53:36 AM
Respert, I’m sure you are at leas (4)
CYDY CytoDyn Inc
12/13/2020 9:53:17 AM
Techguru and Ohm20, I’m not going (5)
CYDY CytoDyn Inc
12/10/2020 9:48:17 AM
Cytodyn has no affirmative obligati (7)
CYDY CytoDyn Inc
12/10/2020 9:45:54 AM
Seriously, pound sand. Patterson di (14)
CYDY CytoDyn Inc
12/10/2020 8:37:39 AM
Goosebumps, I believe that Pfizer h
CYDY CytoDyn Inc
12/10/2020 8:34:00 AM
EnemyofPluto, I believe it is actua (2)
Go to page:
  • << First
  • < Previous
  • 14
  • 15
  • Next >

Recent Articles

  • KALA BIO Advances Its Clinical Trials and Financial Snapshot
  • Elevating Luxury Retail with Conversational AI Solutions
  • Local Bounti Announces Upcoming Financial Results Release
  • Trident Digital Tech Aims for Stablecoin Expansion in Africa
  • Insight into Apax Global Alpha's Recent Market Movements
  • Myseum, Inc. Transforms Digital Media Sharing Landscape
  • Groundbreaking Interim Findings on Assembly Biosciences' ABI-5366
  • MAX Power Mining Achieves Major Financing of $4.45 Million
  • Unveiling IHL-42X: A Breakthrough in Sleep Apnea Treatment
  • Silicon Motion's Exciting Agenda at Upcoming Investor Events
  • Vaxart Leadership Updates Stockholders on Future Plans
  • Quantum BioPharma's PET Tracer Shows Hope for MS Patients
  • Enhancing Healthcare: Scott R. Burell Joins DIH Board Leadership
  • CG Oncology's Latest Financial Insights and Development Progress
  • Board Transformation at Gauzy Ltd. Boosts Future Growth Prospects
  • Tenaya Therapeutics to Showcase Innovative Heart Disease Solutions
  • Upcoming Conferences for Silicon Motion Technology Corp
  • TTM Technologies Ranks High with CMMC Level 2 Certification
  • Vibration Monitoring Market Trends and Future Insights
  • LM Funding America Reports Strong Operational Growth for July 2025
  • Tenaya Therapeutics CEO to Speak at Annual Growth Conference
  • Nutriband Advances Aversa™ Fentanyl Patch Development
  • Scott R. Burell Joins DIH Holding US, Inc. Board of Directors
  • Oxford Lane Capital Corp. Announces July 2025 NAV Insights
  • Exciting Announcement: Dycom Industries Q2 2026 Call Details
  • Rogers Sugar Inc. Holds Important Call for Q3 Insights
  • Altus Group Declares Q3 Dividend Enhancing Shareholder Value
  • Tempus AI, Inc. Class Action Lawsuit: Important Investor Alerts
  • Discover the Exciting New Features of Bybit Web3
  • Assembly Biosciences Secures $175 Million from Equity Financing
  • Brown Plus Elevates Courtney Catlin to Learning Manager Role
  • Investment Insights: Featured Stocks from CNBC's Analysis
  • Jennmar's Strategic Move: Acquiring Weber Mining to Enhance Solutions
  • Accel-KKR Announces $1.9 Billion Fund for isolved Growth
  • Embick Enterprises, Inc. Extends Roofing Services in Florida
  • Explore the 2026 Dodge Durango SRT Hellcat Jailbreak Options
  • Targa Invites Investors to Join Private Placement for Growth
  • CODIT Unveils Innovative AI Policy Solutions at APEC Forum
  • The Alkaline Water Company Achieves Key Audit Success for Uplisting
  • Trulieve Cannabis Corp. Unveils Upcoming Event Plans
  • Revolutionizing News Access: LG Channels' User-Centric Approach
  • CSL's ANDEMBRY® Receives Health Canada Approval for HAE Care
  • Gregory M. Yaffa Achieves Fellowship in Trial Law Recognition
  • AMETEK Announces Quarterly Dividend for Shareholders
  • Telephone and Data Systems Declares Q3 Dividends for 2025
  • Equinix Leadership Set to Engage Investors at Key Conferences
  • Craveworthy Brands Partners with Gregorys Coffee for Growth
  • Explore Metallus's Q2 2025 Earnings Call and Insights
  • HOPE Therapeutics Achieves Major Step Forward with Dura Medical
  • Community Meeting in Harlem: Addressing Legionnaires' Disease
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site